Clinical Trials Directory

Trials / Completed

CompletedNCT02714127

Standard Operating Procedures for Cervical (Pre)Cancer Biomarker Detection in First-void Urine (BM-SOP Study)

Collection of First-void Urine Samples for the Development of Standard Operating Procedures for Cervical (Pre)Cancer Biomarker Detection in First-void Urine: the BM-SOP Study

Status
Completed
Phase
Study type
Observational
Enrollment
128 (actual)
Sponsor
Universiteit Antwerpen · Academic / Other
Sex
Female
Age
25 Years – 64 Years
Healthy volunteers
Accepted

Summary

The aim of the study is to develop robust analytical protocols for first-void urine sample preparation and biomarker assays to analyze a panel of biomarkers in first-void urine for improved diagnosis of cervical (pre)cancer lesions.

Detailed description

In total 100 women will be included in this trial, women diagnosed with abnormal cytology results and/or high risk HPV (Human Papillomavirus) infection scheduled for a colposcopy exam. These women are asked to collect a first-void urine sample with the Colli-PeeTM device, prior to their colposcopy exam at the clinic. The collected urine samples will be used for the development and optimisation of robust analytical protocols for first-void urine sample preparation and biomarker assays. During colposcopy, the cervix will be visually inspected, whether or not combined with a biopsy for histological confirmation. Colposcopy is a procedure to identify abnormalities by using a colposcope that gives an illuminated, magnified view of the cervical region. It often includes rinsing the cervicovaginal region with 50 ml acetic acid (5%). Here, this fluid will be collected and serve as the intermediate step between biomarkers in cervicovaginal secretions and urine.

Conditions

Interventions

TypeNameDescription
OTHERFirst-void urine collectionOne time collection of ca. 20ml of first-void urine (i.e. the initial stream of the urine void) with the Colli-PeeTM device (Novosanis).
OTHERCervicovaginal lavage fluid collectionDuring colposcopy, the cervicovaginal region is rinsed for 2 minutes with 50 ml acetic acid (5%). This fluid is not discarded like it is done usually, but the remaining lavage fluid (5% acetic acid containing cervicovaginal fluid) will be collected.

Timeline

Start date
2015-09-01
Primary completion
2016-12-01
Completion
2016-12-01
First posted
2016-03-21
Last updated
2017-06-15

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT02714127. Inclusion in this directory is not an endorsement.